Serum adipocyte fatty acid-binding protein levels are independently associated with sarcopenic obesity

Diabetes Research and Clinical Practice

Volumn 101, Issue 2, 2013, Pages 210-217

  Kim, Tae Nyun ^a,c   Won, Jong Chul ^a,c   Kim, You Jeong ^a   Lee, Eun Ju ^a   Kim, Mi Kyung ^a   Park, Man Sik ^b   Lee, Seong Keon ^b   Kim, Jung Min ^a,c   Ko, Kyung Soo ^a,c   Rhee, Byoung Doo ^a,c  

^a Inje University College of Medicine   (South Korea)

^b Sungshin Women's University   (South Korea)

^c Inje University   (South Korea)

Author keywords

Adipocyte fatty acid binding protein; Adipokines; Appendicular skeletal muscle mass; Sarcopenic obesity; Visceral obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID BINDING PROTEIN 4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; KOREAN; LEAN BODY WEIGHT; MALE; MUSCLE MASS; NORMAL HUMAN; OBESITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; SARCOPENIA; SEX DIFFERENCE; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT HEIGHT RATIO;

EID: 84881258187     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.05.014     Document Type: Article

References (35)

1. Beaufrere B., Morio B. Fat and protein redistribution with aging: metabolic considerations. Eur J Clin Nutr 2000, 54(Suppl. 3):S48-S53.
2. Newman A.B., Lee J.S., Visser M., Goodpaster B.H., Kritchevsky S.B., Tylavsky F.A., et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. Am J Clin Nutr 2005, 82:872-878. quiz 915-876.
3. Stenholm S., Harris T.B., Rantanen T., Visser M., Kritchevsky S.B., Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008, 11:693-700.
4. Zamboni M., Mazzali G., Fantin F., Rossi A., Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 2008, 18:388-395.
5. Kim T.N., Yang S.J., Yoo H.J., Lim K.I., Kang H.J., Song W., et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond) 2009, 33:885-892.
6. Stephen W.C., Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 2009, 13:460-466.
7. Makowski L., Hotamisligil G.S. Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004, 134:2464S-2468S.
8. Xu A., Wang Y., Xu J.Y., Stejskal D., Tam S., Zhang J., et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006, 52:405-413.
9. Coe N.R., Bernlohr D.A. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta 1998, 1391:287-306.
10. Hertzel A.V., Bernlohr D.A. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab 2000, 11:175-180.
11. Uysal K.T., Scheja L., Wiesbrock S.M., Bonner-Weir S., Hotamisligil G.S. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 2000, 141:3388-3396.
12. Furuhashi M., Tuncman G., Gorgun C.Z., Makowski L., Atsumi G., Vaillancourt E., et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007, 447:959-965.
13. Tso A.W., Xu A., Sham P.C., Wat N.M., Wang Y., Fong C.H., et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 2007, 30:2667-2672.
14. Xu A., Tso A.W., Cheung B.M., Wang Y., Wat N.M., Fong C.H., et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007, 115:1537-1543.
15. Yeung D.C., Xu A., Cheung C.W., Wat N.M., Yau M.H., Fong C.H., et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:1796-1802.
16. Fischer H., Gustafsson T., Sundberg C.J., Norrbom J., Ekman M., Johansson O., et al. Fatty acid binding protein 4 in human skeletal muscle. Biochem Biophys Res Commun 2006, 346:125-130.
17. Maeda K., Cao H., Kono K., Gorgun C.Z., Furuhashi M., Uysal K.T., et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 2005, 1:107-119.
18. Cao H., Maeda K., Gorgun C.Z., Kim H.J., Park S.Y., Shulman G.I., et al. Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice. Diabetes 2006, 55:1915-1922.
19. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res 2004, 12:887-888.
20. Tuncman G., Erbay E., Hom X., De Vivo I., Campos H., Rimm E.B., et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci USA 2006, 103:6970-6975.
21. Bonen A., Luiken J.J., Glatz J.F. Regulation of fatty acid transport and membrane transporters in health and disease. Mol Cell Biochem 2002, 239:181-192.
22. Deiuliis J., Shin J., Murphy E., Kronberg S.L., Eastridge M.L., Suh Y., et al. Bovine adipose triglyceride lipase is not altered and adipocyte fatty acid-binding protein is increased by dietary flaxseed. Lipids 2010, 45:963-973.
23. Xie Y., Newberry E.P., Kennedy S.M., Luo J., Davidson N.O. Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice. J Lipid Res 2009, 50:977-987.
24. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002, 50:889-896.
25. Lim S., Kim J.H., Yoon J.W., Kang S.M., Choi S.H., Park Y.J., et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010, 33:1652-1654.
26. Oh S.W. Obesity and metabolic syndrome in Korea. Diabete Metab 2011, 35:561-566.
27. Cabre A., Lazaro I., Girona J., Manzanares J.M., Marimon F., Plana N., et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 2007, 195:e150-e158.
28. Reinehr T., Stoffel-Wagner B., Roth C.L. Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metabolism 2007, 56:1735-1741.
29. Damon M., Louveau I., Lefaucheur L., Lebret B., Vincent A., Leroy P., et al. Number of intramuscular adipocytes and fatty acid binding protein-4 content are significant indicators of intramuscular fat level in crossbred Large White×Duroc pigs. J Anim Sci 2006, 84:1083-1092.
30. Cesari M., Kritchevsky S.B., Baumgartner R.N., Atkinson H.H., Penninx B.W., Lenchik L., et al. Sarcopenia, obesity, and inflammation - results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 2005, 82:428-434.
31. Schaap L.A., Pluijm S.M., Deeg D.J., Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006, 119:526.e9-526.e17.
32. Schaap L.A., Pluijm S.M., Deeg D.J., Harris T.B., Kritchevsky S.B., Newman A.B., et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009, 64:1183-1189.
33. Tonjes A., Kralisch S., Lossner U., Kovacs P., Bluher M., Stumvoll M., et al. Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein. Int J Obes (Lond) 2012, 36(6):766-773.
34. Sommer G., Ziegelmeier M., Bachmann A., Kralisch S., Lossner U., Kratzsch J., et al. Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf) 2008, 69:901-905.
35. Toruner F., Altinova A.E., Akturk M., Kaya M., Arslan E., Bukan N., et al. The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 2011, 91:203-207.